Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioNTech
Biotech
BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal
BioNTech is buying fellow German mRNA vaccine developer CureVac in an all-stock transaction that values the acquired biotech at $1.25 billion.
James Waldron
Jun 12, 2025 8:17am
BMS inks $11B biobucks BioNTech deal to join bispecific rush
Jun 2, 2025 8:59am
BioNTech makes £1B commitment to expand UK research, build HQ
May 20, 2025 11:15am
BioNTech backing powers DualityBio toward $200M Hong Kong IPO
Apr 7, 2025 8:21am
BioNTech posts survival data behind bispecific's phase 3 push
Mar 28, 2025 8:00am
BioNTech passes on Autolus' CAR-T amid pipeline prioritization
Mar 20, 2025 9:11am
